In this issue:
Front-line TROP2-directed ADC combo prolongs PFS in advanced NSCLC
Dual immunotherapy may negate need for surgery in early dMMR rectal cancer
No benefit to radiotherapy dose escalation in resectable glioblastoma
Perioperative therapy does not prolong survival in colorectal peritoneal metastases
Discord between geriatric patients’ preferences and treatment adverse events
Dual HER2/PI3K pathway targeting for treatment refractory HER2+ breast cancer
Final survival analysis from WSG TP-11 breast cancer trial
Canine multicancer breath detection system could revolutionise cancer screening
Notable cancer risk with latest Australian alcohol guideline limits
Intensified TNT is feasible for high-risk non-metastatic rectal cancer
Please login below to download this issue (PDF)